by angelliu | Jan 3, 2019 | News
Source: BusinessWire Bristol-Myers Squibb Company (NYSE:BMY) and Celgene Corporation (NASDAQ:CELG) today announced that they have entered into a definitive merger agreement under which Bristol-Myers Squibb will acquire Celgene in a cash and stock transaction with an...
by angelliu | Oct 2, 2018 | News
Source: FierceHealthcare With new competitors closing in, UnitedHealth is bolstering its defenses by purchasing Genoa Healthcare, the fifth-largest pharmacy chain in the country with 435 locations. Genoa—which also offers telepsychiatry services and medication...
by angelliu | Aug 13, 2018 | Testimonials
“You are simply the best at what you do. What a powerful resource and great business partner.” – Director, U.S. Training and Leadership Development, Biopharmaceuticals
by angelliu | Aug 3, 2018 | News
Source: FiercePharma Allergan, which is shopping assets to help turn its stock price around, has taken its first small step into selloff land. Spain’s Almirall said Friday it had agreed to pick up a portfolio of medical dermatology products from the Dublin drugmaker...
by angelliu | Jul 31, 2018 | News
Source: Reuters FRANKFURT (Reuters) – Bayer has agreed to sell its established prescription dermatology brands to Denmark’s Leo Pharma, as the German drugmaker focuses on integrating seed maker Monsanto and on bolstering its drug development pipeline. The...
